HANMI FINANCIAL CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that HANMI FINANCIAL CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $270.17M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $234.36M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $255.45M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $271.85M | Feb 28, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $76.09M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $62.20M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $80.04M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $101.39M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $98.68M | Feb 29, 2024 |
| FY2020 | Dec 31, 2020 | $14.33M | Mar 1, 2021 |
| FY2020 | Sep 30, 2020 | $16.34M | Mar 1, 2021 |
| FY2020 | Jun 30, 2020 | $9.18M | Mar 1, 2021 |
| FY2020 | Mar 31, 2020 | $2.35M | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | $3.08M | Mar 1, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $76.09M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $62.20M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $80.04M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $101.39M | Feb 28, 2025 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $206.01M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $52.56M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $109.26M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $147.31M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $93.73M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $60.20M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $58.80M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $76.64M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $81.66M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $59.35M | Mar 1, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $3.70M | Mar 1, 2019 |
| FY2018 | Dec 31, 2017 | $843.0K | Mar 1, 2019 |
| FY2018 | Dec 31, 2016 | $730.0K | Mar 1, 2019 |
| FY2017 | Dec 31, 2015 | $1.15M | Mar 1, 2018 |
| FY2016 | Dec 31, 2014 | $1.15M | Mar 1, 2017 |
| FY2015 | Dec 31, 2013 | $1.02M | Feb 29, 2016 |
| FY2014 | Dec 31, 2012 | $675.0K | Mar 16, 2015 |
| FY2013 | Dec 31, 2011 | $1.17M | Mar 17, 2014 |
| FY2012 | Dec 31, 2010 | $1.23M | Mar 15, 2013 |
| FY2011 | Dec 31, 2009 | $988.0K | Mar 14, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.87B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $7.68B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $7.57B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $7.38B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $6.86B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $6.20B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $5.54B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $5.50B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $5.21B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $4.70B | Mar 1, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.07B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $6.95B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $6.87B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $6.74B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $6.22B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $5.62B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $4.97B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $4.95B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $4.65B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $4.17B | Mar 1, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $796.39M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $732.17M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $701.89M | Feb 27, 2026 |
| FY2025 | Dec 31, 2022 | $637.52M | Feb 27, 2026 |
| FY2024 | Dec 31, 2021 | $643.42M | Feb 28, 2025 |
| FY2023 | Dec 31, 2020 | $577.04M | Feb 29, 2024 |
| FY2022 | Dec 31, 2019 | $563.27M | Feb 28, 2023 |
| FY2021 | Dec 31, 2018 | $552.57M | Feb 28, 2022 |
| FY2020 | Dec 31, 2017 | $562.48M | Mar 1, 2021 |
| FY2019 | Dec 31, 2016 | $531.03M | Mar 2, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.03M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $11.03M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $11.03M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $11.03M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $11.03M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $11.03M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $11.03M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $11.03M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $11.03M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $11.03M | Mar 1, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $394.34M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $350.87M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $319.05M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $269.54M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $196.78M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $114.62M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $100.55M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $97.54M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $70.58M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $41.73M | Mar 1, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 29, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Mar 1, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 29, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Mar 1, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 29.89M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 30.20M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | 30.37M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | 30.49M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | 30.41M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | 30.72M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | 30.80M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | 30.93M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | 32.43M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | 32.33M | Mar 1, 2018 |